TY - JOUR T1 - Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells JF - Molecular Pharmacology JO - Mol Pharmacol DO - 10.1124/mol.107.042382 AU - Elisa Giovannetti AU - Clara Lemos AU - Christina Tekle AU - Kees Smid AU - Sara Nannizzi AU - Jose A Rodriguez AU - Simona Ricciardi AU - Romano Danesi AU - Giuseppe Giaccone AU - Godefridus J Peters Y1 - 2008/01/10 UR - http://molpharm.aspetjournals.org/content/early/2008/01/10/mol.107.042382.abstract N2 - 300 Multiple ChoicesThis is a pdf-only article and there is no markup to show you.full-text.pdf ER -